HORSHAM, Pa., Oct. 29, 2015 (GLOBE NEWSWIRE) — MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release third quarter financial results on Thursday, November 12, after the market close. MELA Sciences President and Chief Executive Officer, Michael Stewart, and Robert Cook, Chief Financial Officer, will host a conference call at 4:30pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, November 12 |
| Time: | 4:30pm Eastern Time |
| Toll Free: | 888-430-8691 |
| International: | 719-325-2376 |
| Passcode: | 714691 |
| Webcast: | www.melasciences.com |
| Replays, available through November 26, 2015 | |
| Toll Free: | 877-870-5176 |
| International: | 858-384-5517 |
| Replay PIN: | 714691 |
About MELA Sciences, Inc. (www.melasciences.com)
MELA Sciences is a medical technology company focused in the dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the MelaFind System used to assist in the identification and management of melanoma skin cancer.
CONTACT: Investor Contacts:
Robert W. Cook
MELA Sciences, Inc.
914 373 6936
rcook@melasciences.com
Andrew McDonald
LifeSci Advisors, LLC
646-597-6987
Andrew@LifeSciAdvisors.com
